Development and Prospective Randomized Evaluation of a Decision Aid for Prostate-specific Antigen-based Early Detection of Prostate Cancer in Men Aged Between 55 and 69Yr: The PSAInForm Trial

Eur Urol. 2019 Jul;76(1):1-3. doi: 10.1016/j.eururo.2019.01.008. Epub 2019 Jan 18.

Abstract

For men interested in early detection of prostate cancer, the potential impact on decisional conflict of a decision aid with or without cost compensation for the prostate-specific antigen test will be investigated.

Publication types

  • Clinical Trial Protocol
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Biopsy
  • Decision Support Techniques*
  • Directive Counseling
  • Early Detection of Cancer* / economics
  • Early Detection of Cancer* / methods
  • Fees and Charges
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Prostate / pathology
  • Prostate-Specific Antigen* / blood
  • Prostatic Neoplasms* / blood
  • Prostatic Neoplasms* / diagnosis
  • Randomized Controlled Trials as Topic

Substances

  • Prostate-Specific Antigen